[The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas].
| Title: | [The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas]. |
|---|---|
| Transliterated Title: | A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas. |
| Authors: | Page MJ; Monash University School of Public Health and Preventive Medicine Melbourne Austrália Monash University, School of Public Health and Preventive Medicine, Melbourne, Austrália.; McKenzie JE; Monash University School of Public Health and Preventive Medicine Melbourne Austrália Monash University, School of Public Health and Preventive Medicine, Melbourne, Austrália.; Bossuyt PM; University of Amsterdam Amsterdam University Medical Centres Amsterdã Holanda University of Amsterdam, Amsterdam University Medical Centres, Amsterdã, Holanda.; Boutron I; Université de Paris Centre of Epidemiology and Statistics Paris França Université de Paris, Centre of Epidemiology and Statistics, Paris, França.; Hoffmann TC; Bond University Faculty of Health Sciences and Medicine Gold Coast Austrália Bond University, Faculty of Health Sciences and Medicine, Gold Coast, Austrália.; Mulrow CD; University of Texas Health Science Center at San Antonio San AntonioTexas Estados Unidos University of Texas Health Science Center at San Antonio, San Antonio, Texas, Estados Unidos.; Shamseer L; University of Ottawa School of Epidemiology and Public Health Ottawa Canadá University of Ottawa, School of Epidemiology and Public Health, Ottawa, Canadá.; Tetzlaff JM; Evidence Partners Ottawa Canadá Evidence Partners, Ottawa, Canadá.; Akl EA; American University of Beirut Clinical Research Institute Beirute Líbano American University of Beirut, Clinical Research Institute, Beirute, Líbano.; Brennan SE; Monash University School of Public Health and Preventive Medicine Melbourne Austrália Monash University, School of Public Health and Preventive Medicine, Melbourne, Austrália.; Chou R; Oregon Health & Science University Department of Medical Informatics and Clinical Epidemiology PortlandOregon Estados Unidos Oregon Health & Science University, Department of Medical Informatics and Clinical Epidemiology, Portland, Oregon, Estados Unidos.; Glanville J; University of York York Health Economics Consortium York Reino Unido University of York, York Health Economics Consortium, York, Reino Unido.; Grimshaw JM; Ottawa Hospital Research Institute Clinical Epidemiology Program Ottawa Canadá Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canadá.; Hróbjartsson A; University of Southern Denmark Department of Clinical Research Odense Dinamarca University of Southern Denmark, Department of Clinical Research, Odense, Dinamarca.; Lalu MM; Ottawa Hospital Department of Anesthesiology and Pain Medicine Ottawa Canadá Ottawa Hospital, Department of Anesthesiology and Pain Medicine, Ottawa, Canadá.; Li T; University of Colorado Denver School of Medicine DenverClorado United States University of Colorado Denver, School of Medicine, Denver, Colorado, United States.; Loder EW; Harvard Medical School Brigham and Women's Hospital BostonMassachusetts Estados Unidos Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, Estados Unidos.; Mayo-Wilson E; Indiana University School of Public Health-Bloomington Department of Epidemiology and Biostatistics BloomingtonIndiana Estados Unidos Indiana University School of Public Health-Bloomington, Department of Epidemiology and Biostatistics, Bloomington, Indiana, Estados Unidos.; McDonald S; Monash University School of Public Health and Preventive Medicine Melbourne Austrália Monash University, School of Public Health and Preventive Medicine, Melbourne, Austrália.; McGuinness LA; University of Bristol Bristol Medical School Bristol Reino Unido University of Bristol, Bristol Medical School, Bristol, Reino Unido.; Stewart LA; University of York Centre for Reviews and Dissemination York Reino Unido University of York, Centre for Reviews and Dissemination, York, Reino Unido.; Thomas J; University College London Social Research Institute London Reino Unido University College London, Social Research Institute, London, Reino Unido.; Tricco AC; University of Toronto Institute of Health Management, Policy, and Evaluation Toronto Canadá University of Toronto, Institute of Health Management, Policy, and Evaluation, Toronto, Canadá.; Welch VA; Bruyère Research Institute Methods Centre OttawaOntario Canadá Bruyère Research Institute, Methods Centre, Ottawa, Ontario, Canadá.; Whiting P; University of Bristol Bristol Medical School Bristol Reino Unido University of Bristol, Bristol Medical School, Bristol, Reino Unido.; Moher D; Ottawa Hospital Research Institute centre for Journalology Ottawa Canadá Ottawa Hospital Research Institute, centre for Journalology, Ottawa, Canadá. |
| Source: | Revista panamericana de salud publica = Pan American journal of public health [Rev Panam Salud Publica] 2022 Dec 30; Vol. 46, pp. e112. Date of Electronic Publication: 2022 Dec 30 (Print Publication: 2022). |
| Publication Type: | Case Reports; English Abstract; Journal Article |
| Language: | Portuguese |
| Journal Info: | Publisher: Pan American Health Organization Country of Publication: United States NLM ID: 9705400 Publication Model: eCollection Cited Medium: Internet ISSN: 1680-5348 (Electronic) Linking ISSN: 10204989 NLM ISO Abbreviation: Rev Panam Salud Publica Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Washington, D.C. : Pan American Health Organization, [1997?- |
| Abstract: | The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews. |
| References: | PLoS Med. 2016 May 24;13(5):e1002028. (PMID: 27218655); Syst Rev. 2012 Feb 09;1:1. (PMID: 22587946); Ann Intern Med. 2015 Jun 2;162(11):777-84. (PMID: 26030634); J Clin Epidemiol. 2016 Jan;69:225-34. (PMID: 26092286); Ann Intern Med. 2018 Oct 2;169(7):467-473. (PMID: 30178033); PLoS Med. 2013;10(4):e1001419. (PMID: 23585737); BMJ. 2016 Feb 01;352:i157. (PMID: 26830668); Nat Hum Behav. 2020 Jan;4(1):4-6. (PMID: 31792401); Phys Ther. 2009 Sep;89(9):873-80. (PMID: 19723669); J Clin Epidemiol. 2017 Jul;87:4-13. (PMID: 28529184); Syst Rev. 2019 Jul 11;8(1):163. (PMID: 31296265); PLoS Med. 2007 Mar 27;4(3):e78. (PMID: 17388659); PLoS Med. 2012;9(10):e1001333. (PMID: 23222917); Ann Intern Med. 2009 Aug 18;151(4):264-9, W64. (PMID: 19622511); BMJ. 2009 Jul 21;339:b2700. (PMID: 19622552); Res Synth Methods. 2018 Mar;9(1):2-12. (PMID: 29057573); BMC Med Res Methodol. 2012 Nov 27;12:181. (PMID: 23185978); PLoS Med. 2009 Jul 21;6(7):e1000097. (PMID: 19621072); PLoS Med. 2009 Jul 21;6(7):e1000100. (PMID: 19621070); Syst Rev. 2012 Feb 09;1:2. (PMID: 22587842); Res Synth Methods. 2018 Dec;9(4):602-614. (PMID: 29314757); Syst Rev. 2015 Jan 14;4:5. (PMID: 25588314); BMC Med. 2015 Sep 15;13:221. (PMID: 26370288); JAMA. 2018 Jan 23;319(4):388-396. (PMID: 29362800); Int J Surg. 2016 Jun;30:169-72. (PMID: 27112835); BMJ. 2015 Jan 02;350:g7647. (PMID: 25555855); J Clin Epidemiol. 2019 Nov;115:46-54. (PMID: 31254618); BMC Complement Altern Med. 2019 Aug 12;19(1):208. (PMID: 31405367); Open Med. 2009;3(3):e123-30. (PMID: 21603045); Syst Rev. 2019 Jul 15;8(1):170. (PMID: 31307555); BMJ Open. 2020 Mar 19;10(3):e035114. (PMID: 32198306); Syst Rev. 2017 Dec 19;6(1):263. (PMID: 29258593); Ann Intern Med. 2009 Aug 18;151(4):W65-94. (PMID: 19622512); BMC Med Res Methodol. 2019 Jan 31;19(1):25. (PMID: 30709371); BMC Med. 2010 Apr 26;8:24. (PMID: 20420659); BMJ. 2017 Sep 21;358:j4008. (PMID: 28935701); Res Integr Peer Rev. 2019 Jun 12;4:12. (PMID: 31205756); Syst Rev. 2014 May 29;3:54. (PMID: 24886533); Heart. 2018 Feb;104(3):192-200. (PMID: 29030423); BMJ. 2016 Oct 12;355:i4919. (PMID: 27733354); Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142. (PMID: 31643080); J Clin Epidemiol. 2018 Mar;95:7-18. (PMID: 29203419); Syst Rev. 2015 Jan 01;4:1. (PMID: 25554246); PLoS Med. 2010 Feb 16;7(2):e1000217. (PMID: 20169112); PLoS One. 2013 Dec 26;8(12):e83138. (PMID: 24386151); BMJ. 2019 Aug 28;366:l4898. (PMID: 31462531); PLoS Med. 2019 Feb 21;16(2):e1002742. (PMID: 30789892); J Clin Epidemiol. 2009 Oct;62(10):e1-34. (PMID: 19631507); BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000858. (PMID: 30775014); BMC Med. 2019 Nov 19;17(1):205. (PMID: 31744489); BMJ. 2014 Jun 25;348:g3804. (PMID: 24965222); BMJ. 2009 Jul 21;339:b2535. (PMID: 19622551); BMJ Open. 2019 May 9;9(5):e026589. (PMID: 31076472); JAMA. 2015 Apr 28;313(16):1657-65. (PMID: 25919529); J Clin Epidemiol. 2018 Feb;94:8-18. (PMID: 29113936); J Clin Epidemiol. 2020 Feb;118:60-68. (PMID: 31740319); BMJ. 2021 Mar 29;372:n160. (PMID: 33781993); Nature. 2018 Mar 7;555(7695):175-182. (PMID: 29517004); BMC Med. 2018 Dec 14;16(1):233. (PMID: 30545364); J Clin Epidemiol. 2021 Jun;134:103-112. (PMID: 33577987); Syst Rev. 2017 Sep 8;6(1):185. (PMID: 28886726); Syst Rev. 2021 Jan 26;10(1):39. (PMID: 33499930); J Clin Epidemiol. 2009 Oct;62(10):1006-12. (PMID: 19631508); BMJ. 2020 Jan 16;368:l6890. (PMID: 31948937); JAMA Oncol. 2019 Nov 01;5(11):1550-1555. (PMID: 31486837); Int J Surg. 2010;8(5):336-41. (PMID: 20171303) |
| Grant Information: | UG1 EY020522 United States EY NEI NIH HHS |
| Contributed Indexing: | Keywords: Guideline; medical writing; meta-analysis; systematic review; Local Abstract: [Publisher, Spanish; Castilian] La declaración PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), publicada en 2009, se diseñó para ayudar a los autores de revisiones sistemáticas a documentar de manera transparente el porqué de la revisión, qué hicieron los autores y qué encontraron. Durante la última década, ha habido muchos avances en la metodología y terminología de las revisiones sistemáticas, lo que ha requerido una actualización de esta guía. La declaración PRISMA 2020 sustituye a la declaración de 2009 e incluye una nueva guía de presentación de las publicaciones que refleja los avances en los métodos para identificar, seleccionar, evaluar y sintetizar estudios. La estructura y la presentación de los ítems ha sido modificada para facilitar su implementación. En este artículo, presentamos la lista de verificación PRISMA 2020 con 27 ítems, y una lista de verificación ampliada que detalla las recomendaciones en la publicación de cada ítem, la lista de verificación del resumen estructurado PRISMA 2020 y el diagrama de flujo revisado para revisiones sistemáticas. |
| Entry Date(s): | Date Created: 20230105 Latest Revision: 20240910 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC9798848 |
| DOI: | 10.26633/RPSP.2022.112 |
| PMID: | 36601438 |
| Database: | MEDLINE |
Case Reports; English Abstract; Journal Article